A 3D-Printable, Low-Cost Obturator for Less Invasive Gynecologic Brachytherapy.
dosimetry plan
gynecologic and reproductive tumors/malignancies
gynecologic cancers
high dose rate interstitial brachytherapy
intracavitary therapy brachytherapy
invasive cervical cancer
medical device technology
prototype design
three-dimensional (3d) printing
treatment of cervical cancer
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
accepted:
29
06
2023
medline:
1
8
2023
pubmed:
1
8
2023
entrez:
1
8
2023
Statut:
epublish
Résumé
The purpose of this report is to design, develop, and evaluate a cost-effective applicator for interstitial brachytherapy (ISBT) to minimize patient morbidity and facilitate access to curative radiation treatment for gynecologic cancers, especially in low-resource settings. A computer-aided design and prototype were developed of a proposed applicator that incorporates 44 slotted channels to gently guide needles, with or without a tandem, through the vaginal canal, effectively eliminating the need for transcutaneous needle insertions typically employed during ISBT of advanced gynecologic cancer and thus reducing the risk of vaginal laceration and bladder or rectal injury. The tested prototype was developed using AutoCAD software (Autodesk, San Francisco, CA) and 3D printed in Accura Xtreme Gray material using stereolithography. Small-scale iterative tests using a gelatin phantom were conducted on this prototype to confirm the efficacy of the applicator through inter-operator usability, needle stability, and needle arrangement. A promising prototype was developed aimed at addressing key issues with traditional perineum-based templates to facilitate ISBT, including being able to cover bulky tumors with parametrial extension reliably, decrease the risk of tissue or organ injury, and treat women with a prior hysterectomy. Results of preclinical testing demonstrated that the applicator met its purpose, suggesting that it may facilitate ISBT without the morbidity typically associated with the procedure, especially by addressing concerns associated with implementing the procedure in low-resource settings. The applicator shows substantial promise in the treatment of advanced gynecologic cancer. While further testing remains necessary to confirm its translatability to the clinical setting, the applicator appears capable of meeting its design objectives, representing its potential for improving upon current methods.
Identifiants
pubmed: 37525761
doi: 10.7759/cureus.41162
pmc: PMC10387167
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e41162Informations de copyright
Copyright © 2023, Rane et al.
Déclaration de conflit d'intérêts
A patent on this device has been obtained in the United States (ID: 20220184417) on June 16, 2022.
Références
Phys Med Biol. 2005 Dec 7;50(23):5597-618
pubmed: 16306655
J Glob Oncol. 2016 May 25;2(5):311-340
pubmed: 28717717
Int J Womens Health. 2014 May 28;6:555-64
pubmed: 24920937
3D Print Med. 2019 May 16;5(1):8
pubmed: 31098743
Oncol Lett. 2020 Sep;20(3):2058-2074
pubmed: 32782524
Front Oncol. 2016 Jun 28;6:160
pubmed: 27446806
Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):88-94
pubmed: 29079120
Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):88-95
pubmed: 24725693
J Contemp Brachytherapy. 2016 Jun;8(3):208-14
pubmed: 27504130
Brachytherapy. 2014 Jan-Feb;13(1):100-9
pubmed: 24269145
Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):111-9
pubmed: 23849695